Projects per year
Abstract
Pelvic organ prolapse (POP) is a hidden women’s health disorder that impacts 1 in 4 women across all age groups. Surgical intervention has been the only treatment option, often involving non-degradable meshes, with variable results. However, recent reports have highlighted the adverse effects of meshes in the long term, which involve unacceptable rates of erosion, chronic infection and severe pain related to mesh shrinkage. Therefore, there is an urgent unmet need to fabricate of new class of biocompatible meshes for the treatment of POP. This review focuses on the causes for the downfall of commercial meshes, and discusses the use of emerging technologies such as electrospinning and 3D printing to design new meshes. Furthermore, we discuss the impact and advantage of nano-/microstructured alternative meshes over commercial meshes with respect to their tissue integration performance. Considering the key challenges of current meshes, we discuss the potential of cell-based tissue engineering strategies to augment the new class of meshes to improve biocompatibility and immunomodulation. Finally, this review highlights the future direction in designing the new class of mesh to overcome the hurdles of foreign body rejection faced by the traditional meshes, in order to have safe and effective treatment for women in the long term.
Original language | English |
---|---|
Article number | 1120 |
Number of pages | 26 |
Journal | Nanomaterials |
Volume | 10 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2020 |
Keywords
- 3D printing foreign body response
- Cell therapy
- Mesh complications
- Nanofiber mesh
- Pelvic organ prolapse
- Tissue engineering
-
Advancing Women’s Urogynecological Health using Micro/Nanotechnologies
Mukherjee, S., Werkmeister, J. A., Wood, B. & Rosamilia, A.
1/01/20 → 31/12/24
Project: Research
-
Cells and nanobiomaterials to treat and prevent Pelvic Organ Prolapse
Gargett, C., Mukherjee, S., Brosens, J. J., Werkmeister, J. A., Rosamilia, A., Deane, J., Ott, S., Arkwright, J. W. & Weiss, A. S.
1/01/19 → 31/12/22
Project: Research
Equipment
-
Histology Platform
Camilla Cohen (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
MHTP Cell Therapies Platform
Gordon McPhee (Manager)
Hudson Institute - Department of Molecular and Translational ScienceFacility/equipment: Facility
-
Ramaciotti Centre for Cryo-Electron Microscopy
Georg Ramm (Manager), Simon Andrew Crawford (Operator), Hariprasad Venugopal (Operator), Joan Marea Clark (Operator) & Gediminas Gervinskas (Operator)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility